Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

被引：0
|
作者：
C Kahlert
H Weber
C Mogler
F Bergmann
P Schirmacher
H G Kenngott
U Matterne
N Mollberg
N N Rahbari
U Hinz
M Koch
M Aigner
J Weitz
机构：
[1] University of Heidelberg,Department of Surgery
[2] Im Neuenheimer Feld 110,undefined
[3] Institute of Pathology,undefined
[4] University of Heidelberg,undefined
[5] Im Neuenheimer Feld 110,undefined
[6] Institute of Occupational and Social medicine,undefined
[7] Voßstrasse 2,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
ALCAM; CD166; ADAM17/TACE; pancreatic cancer; prognostic marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：457 / 464
页数：7
相关论文
共 50 条
  • [11] Expression of ALCAM/CD166 and related proteins in breast cancer: tissue and cell lines
    不详
    BREAST, 2005, 14 : S17 - S17
  • [12] ALCAM/CD166 Is a TGF-β-Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone
    Hansen, Amanda G.
    Arnold, Shanna A.
    Jiang, Ming
    Palmer, Trenis D.
    Ketova, Tatiana
    Merkel, Alyssa
    Pickup, Michael
    Samaras, Susan
    Shyr, Yu
    Moses, Harold L.
    Hayward, Simon W.
    Sterling, Julie A.
    Zijlstra, Andries
    CANCER RESEARCH, 2014, 74 (05) : 1404 - 1415
  • [13] Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population
    Zhou, Ping
    Du, Liang-Feng
    Lv, Guo-Qiang
    Yu, Xian-Ming
    Gu, Yuan-Long
    Li, Jian-Ping
    Zhang, Chun
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 527 - 534
  • [14] Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population
    Ping Zhou
    Liang-Feng Du
    Guo-Qiang Lv
    Xian-Ming Yu
    Yuan-Long Gu
    Jian-Ping Li
    Chun Zhang
    Breast Cancer Research and Treatment, 2011, 128 : 527 - 534
  • [15] The Cancer Stem Cell Marker CD166/Alcam Regulates Signaling Pathways That Govern Intestinal Epithelial Cell Growth
    Smith, Nicholas R.
    Levin, Trevor G.
    Erickson, Crystal J.
    Bubbers, Emily J.
    Abe, James
    Wong, Melissa H.
    GASTROENTEROLOGY, 2014, 146 (05) : S84 - S84
  • [16] Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma
    Inaguma, Shingo
    Lasota, Jerzy
    Wang, Zengfeng
    Czapiewski, Piotr
    Langfort, Renata
    Rys, Janusz
    Szpor, Joanna
    Waloszczyk, Piotr
    Okon, Krzysztof
    Biernat, Wojciech
    Ikeda, Hiroshi
    Schrump, David S.
    Hassan, Raffit
    Miettinen, Markku
    HUMAN PATHOLOGY, 2018, 71 : 1 - 7
  • [17] Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism
    Yang, Yiming
    Sanders, Andrew J.
    Ruge, Fiona
    Dong, Xuefei
    Cui, Yuxin
    Dou, Qing Ping
    Jia, Shuqin
    Hao, Chunyi
    Ji, Jiafu
    Jiang, Wen G.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 5917 - +
  • [18] CD166 Expression Characterized Tumorigenicity, and Invasive and Migratory Activities of Pancreatic Cancer Cell Lines
    Fujiwara, K.
    Ohuchida, K.
    Akagawa, S.
    Ohtsuka, T.
    Mizumoto, K.
    Tanaka, M.
    PANCREAS, 2013, 42 (08) : 1349 - 1349
  • [19] CD133 expression is an independent prognostic marker for low survival in colorectal cancer
    D Horst
    L Kriegl
    J Engel
    T Kirchner
    A Jung
    British Journal of Cancer, 2008, 99 : 1285 - 1289
  • [20] CD133 expression is an independent prognostic marker for low survival in colorectal cancer
    Horst, D.
    Kriegl, L.
    Engel, J.
    Kirchner, T.
    Jung, A.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1285 - 1289
12345